Bolt Biotherapeutics
BOLT
BOLT
44 hedge funds and large institutions have $26.8M invested in Bolt Biotherapeutics in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
30% less capital invested
Capital invested by funds: $38.5M → $26.8M (-$11.7M)
92% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 13
Holders
44
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$715K | |
| 2 | +$352K | |
| 3 | +$260K | |
| 4 |
Millennium Management
New York
|
+$162K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$96.7K |
Top Sellers
| 1 | -$5.48M | |
| 2 | -$3.96M | |
| 3 | -$789K | |
| 4 |
BlackRock
New York
|
-$221K |
| 5 |
CCM
CAAS Capital Management
New York
|
-$173K |